|
|
|
Agenda: Day 3
Friday, November 14, 2003
|
8:00 a.m. |
Introduction to Day Three
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals
GlaxoSmithKline
Research Triangle Park, NC
(Conference Co chair)
|
8:15 a.m. |
Federal Enforcement and Prosecution of Pharmaceutical Law and Regulation
John Bentivoglio, Esq.
Partner, Arnold & Porter
Former Special Counsel for Health Care Fraud
Chief Privacy Officer, Department of Justice
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
9:00 a.m. |
State Enforcement and Prosecution of Pharmaceutical Law and Regulation
Alexis Leslie Barbieri, Esq.
Deputy Attorney General
Office of Attorney General
Harrisburg, PA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Handout Material (Acrobat)
Handout Material (Microsoft Word)
|
9:45 a.m. |
Perspective on Pharmaceutical Sales and Marketing Practices
Michael Loucks, Esq.
Chief of the Health Care Fraud Unit
Assistant U.S. Attorney
U.S. Attorney's Office for the District of Massachusetts
Boston, MA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
10:45 a.m. |
Break
|
11:00 a.m. |
CONCURRENT SESSIONS IV
Pharmaceutical Compliance Knowledge Exchange and Best Practices Sessions. The Following Special Sessions are Facilitated Discussions
|
|
4.01 How to Structure Your Compliance Program - Reporting, Scope, Resources and Approach
William T. Fitzgerald, Esq.
Director, Global Compliance
Alcon Laboratories, Inc.
Fort Worth, TX
Gary Giampetruzzi, Esq.
Compliance Counsel, Pfizer Inc.
New York, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Edward Miller, Esq.
Assistant General Counsel
Chief Compliance Officer
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
|
|
4.02 Compliance Training
Brian A. Dahl, Esq.
Senior Counsel, Takeda Pharmaceuticals North America, Inc.
Lincolnshire, IL
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
|
4.03 Compliance Auditing
Teri Crouse, Esq.
Director of Compliance for Healthcare and Marketing
Eli Lilly and Company
Indianapolis, IN
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
|
4.04 Privacy Programs
Mary Devlin Capizzi, Esq.
Partner, Gardner Carton & Douglas
Washington, DC
Stanley W. Crosley, Esq.
Chief Privacy Officer
Eli Lilly and Company, Law Division
Indianapolis, IN
James H. Koenig, Esq.
Practice Co-Leader, Privacy Strategy & Compliance
PricewaterhouseCoopers LLP
Philadelphia, PA
|
|
4.05 Compliance in Clinical Research
Jane L. Stratton, Esq.
Vice President Associate General Counsel and Chief Compliance Officer
Chiron Corporation
Emeryville, CA
|
Noon |
Luncheon and Presentations
|
12:30 p.m. |
Privacy Regulation of the Pharmaceutical Sector Presented by the International Pharmaceutical Privacy Consortium
Joan Antokol
Chief Privacy Officer
Novartis
East Hanover, NJ
John Clay
Senior Adviser, E-Business
North American Commercial Operations
Aventis Pharmaceuticals
Bridgewater, NJ
Oliver Johnson, II
Chief Privacy Officer, Merck & Co.
Whitehouse Station, NJ
Jonathan A. Smollen
Chief Privacy Officer, Wyeth Pharmaceuticals
St. Davids, PA
Stanley W. Crosley, Esq.
Chief Privacy Officer
Eli Lilly and Company, Law Division
Indianapolis, IN
(Moderator)
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
1:30 p.m. |
Pharmaceutical Sector Public Policy Issues
Ian Spatz
Vice President, Public Policy
Merck & Co., Inc.
Washington, DC
|
2:00 p.m. |
Qui Tam Panel
Mark Allen Kleiman, Esq.
Partner, Law Offices of Mark Allen Kleiman
Los Angeles, CA
Stephen Meagher, Esq.
Partner, Phillips & Cohen
San Francisco, CA
Robert G. Homchick, Esq.
Partner and Chair, Health Law Group
Davis Wright Tremaine
Seattle, WA
|
3:00 p.m. |
End Notes: The Future of Pharmaceutical Sector Regulation and Compliance
Janet Rehnquist, Esq.
Partner, Venable LLP
Former Inspector General
Department of Health & Human Services
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
3:30 p.m. |
Adjournment
|
|
